COMMUNIQUÉS West-GlobeNewswire

Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference
24/01/2025
WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]
Dermatology Group of Arkansas Welcomes a New Registered Nurse
24/01/2025
Shelby Brady joins Dermatology Group of Arkansas as an RN focused on skin health for patients in the Little Rock area LITTLE ROCK, Ark., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Dermatology Group of Arkansas is always seeking [...]
Ascentage Pharma Announces Pricing of U.S. Initial Public Offering
24/01/2025
ROCKVILLE, Md. and SUZHOU, China, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U.S. initial public offering of 7,325,000 American depositary shares (“ [...]
NADP Foundation Announces 2025 Grants to Advance Access to Oral Healthcare
23/01/2025
DALLAS, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The National Association of Dental Plans Foundation recently awarded a total of $99,000 to three innovative organizations focused on the advancement of access to oral health [...]
Impact BioMedical Inc. to Present at The Microcap Conference
23/01/2025
HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today [...]
Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
23/01/2025
Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress PARIS, France – January 23, 2025 – 10:05 PM CET – Abivax SA ( [...]
Vincerx Pharma, Inc. Announces Reverse Stock Split
23/01/2025
Vincerx’s Common Stock to Begin Trading on a Split-adjusted Basis on January 28, 2025 SAN MATEO, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to [...]
Intuitive Announces Fourth Quarter Earnings
23/01/2025
SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial [...]
Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich’s Ataxia
23/01/2025
Adolescents receive a weight-based dose equivalent to the 50 mg adult dose Adolescents 12-17 years old who complete participation in the pharmacokinetic (PK) run-in study will be eligible to screen in the ongoing open [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
23/01/2025
Company Announcement COPENHAGEN, Denmark; January 23, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 4,903 restricted stock units and 5,289 warrants to employees of the Company and the [...]
Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3
23/01/2025
NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI
23/01/2025
NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural killer T (iNKT) [...]
Vessl Prosthetics Secures Oversubscribed Pre-Seed Funding to Drive Innovation in Prosthetic Solutions
23/01/2025
LONDON, Ontario, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Vessl, a London-based startup specializing in advanced prosthetic systems, is proud to announce the successful completion of its first funding round, securing [...]
America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search
23/01/2025
The Regeneron Science Talent Search Celebrates and Rewards Today’s Most Talented Young Minds Driving Innovation and Progress through Scientific Exploration TARRYTOWN, N.Y. and WASHINGTON, D.C., Jan. 23, 2025 (GLOBE [...]
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
23/01/2025
HOUSTON, TX, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar today, January 23, 2025, at 4:15 p.m. ET. The [...]
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
23/01/2025
Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced Medicare Price Assignment ROSELAND, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading [...]
Medisensonic S.A. Modern medical technologies with growing investment potential
23/01/2025
WARSAW, Poland, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Medisensonic S.A., a Polish MedTech joint-stock company with an estimated market value of more than €15 million, is one of the very promising players in the market. The [...]
Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer
23/01/2025
Industry changemaker to drive transformation and operational improvements in the development and delivery of the company’s healthcare products, solutions, and services MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- [...]
LAPIX Therapeutics Doses First Patient-In Phase 1b Clinical Trial of LPX-TI641 for Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)
23/01/2025
LPX-TI641 is a novel, orally bioavailable, potent small-molecule immunomodulator that restores immune tolerance by targeting multiple pathways implicated in autoimmune diseases. Topline Phase 1 clinical data for LPX- [...]

Pages